German upper house gives the go-ahead for MPG2
This article was originally published in Clinica
The German medical device industry association (BVMed) has welcomed the upper house's (Bundesrat's) decision to pass the second amendment to the medical devices law (MPG2) last week. BVMed director Joachim Schmitt said that the new law, which will come into force on January 1 2002, clarified the legal position of medical device manufacturers.
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.